Oxaliplatin in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Stage IV Breast Cancer
Interventions: RADIATION: carbon C 14 oxaliplatin|DRUG: oxaliplatin|OTHER: laboratory biomarker analysis
Sponsor: University of California, Davis
Collaborators: National Cancer Institute (NCI)